These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 3992146)
1. Increased plasma level of clotting factors VII and X in hyperlipoproteinemia. Cucuianu M; Popescu TA; Roman S; Bedeleanu D; Păiş R Med Interne; 1985; 23(1):37-43. PubMed ID: 3992146 [TBL] [Abstract][Full Text] [Related]
2. Increased level of the complement C3 protein in endogenous hypertriglyceridemia. Uza G; Cristea A; Cucuianu MP J Clin Lab Immunol; 1982 Jun; 8(2):101-5. PubMed ID: 7108936 [TBL] [Abstract][Full Text] [Related]
3. Antithrombin III deficiency in a Romanian family. Pathogenic role of concomitantly increased plasma level of clotting factors VII and X. Cucuianu M; Comes L; Roman S; Boeru A Med Interne; 1984; 22(1):13-7. PubMed ID: 6710043 [TBL] [Abstract][Full Text] [Related]
4. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Erem C Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444 [TBL] [Abstract][Full Text] [Related]
5. Hyperlipoproteinemia, hemostatic variables and thromboatherosclerosis. Cucuianu M Med Interne; 1988; 26(1):15-20. PubMed ID: 3041550 [TBL] [Abstract][Full Text] [Related]
6. Clinical studies on plasma protein C. Correlation with serum cholinesterase. Cucuianu M; Brudasca I; Trif I; Stancu A Nouv Rev Fr Hematol (1978); 1993; 35(5):481-6. PubMed ID: 8295822 [TBL] [Abstract][Full Text] [Related]
7. Increased values of antipyrine clearance in type IV hyperlipoproteinemia. Bedeleanu D; Trif I; Lötsch JC; Cucuianu MP Med Interne; 1986; 24(3):183-90. PubMed ID: 3775212 [TBL] [Abstract][Full Text] [Related]
8. Behaviour of uricemia in hyperlipoproteinemic subjects. Zdrenghea D; Marta D; Constantinescu M; Cucuianu M Med Interne; 1980; 18(4):385-90. PubMed ID: 7455583 [TBL] [Abstract][Full Text] [Related]
9. Mild liver abnormalities associated with elevated plasma factor VII and protein C in hypertriglyceridaemic patients. Bruckert E; Ankri A; Jung M; Turpin G; De Gennes JL Eur J Med; 1993; 2(8):461-5. PubMed ID: 8258046 [TBL] [Abstract][Full Text] [Related]
10. Effect of abdominal obesity on prothrombotic tendency in type 2 diabetes. Behavior of clotting factors VII and VIII, fibrinogen and von Willebrand Factor. Coca M; Cucuianu M; Hâncu N Rom J Intern Med; 2005; 43(1-2):115-26. PubMed ID: 16739871 [TBL] [Abstract][Full Text] [Related]
11. Apolipoproteins A1 and B levels and serum cholinesterase activity in hyperlipidemic subjects. Olinic D; Stoia M; Marian I; Trif I; Cucuianu M Rom J Intern Med; 1999; 37(1):71-9. PubMed ID: 15523947 [TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation in liver diseases of a new blood coagulation test for the determination of factors II, VII and X]. Pagliano FM; Cestari G; Slucca P Arch Sci Med (Torino); 1976; 133(4):315-20. PubMed ID: 1023839 [TBL] [Abstract][Full Text] [Related]
13. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels. Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067 [TBL] [Abstract][Full Text] [Related]
14. Vitamin K-dependent clotting factors are elevated in young adults who have close relatives with ischemic heart disease. Burns P; Hoffman CJ; Katz JP; Miller RH; Lawson WE; Hultin MB J Lab Clin Med; 1993 Dec; 122(6):720-7. PubMed ID: 8245691 [TBL] [Abstract][Full Text] [Related]
15. [Effects of the administration of vitamin K on the activity of Factor II, VII and X in healthy newborns]. Arteaga-Vizcaíno M; Torres-Espina M; Redondo L; Soto-Torres L; Diez-Ewald M; Vizcaíno-Salazar G; Torres-Guerra E; Fernández N Invest Clin; 1995 Jun; 36(2):83-93. PubMed ID: 7548303 [TBL] [Abstract][Full Text] [Related]
16. Reconstitution of the actin-scavenger system after orthotopic liver transplantation for end-stage liver disease: a prospective and longitudinal study. Schiodt FV; Bondesen S; Müller K; Rasmussen A; Hjortrup A; Kirkegaard P; Hansen BA; Tygstrup N; Ott P Liver Transpl Surg; 1999 Jul; 5(4):310-7. PubMed ID: 10388504 [TBL] [Abstract][Full Text] [Related]
17. Changes of clotting factors (7, 9 and 10) and hepatocyte growth factor in patients with thrombotic microangiopathy after bone marrow transplantation. Takatsuka H; Nakajima T; Nomura K; Okikawa Y; Wakae T; Toda A; Itoi H; Okada M; Misawa M; Hara H; Ogawa H Clin Transplant; 2006; 20(5):640-3. PubMed ID: 16968491 [TBL] [Abstract][Full Text] [Related]
18. Serum cholesterol and apoprotein B levels and serum cholinesterase activity in selected hematologic malignancies. Cucuianu A; Malide D; Petrov L; Patiu M; Vlaicu S; Cucuianu M Rom J Intern Med; 1992; 30(4):261-8. PubMed ID: 1299417 [TBL] [Abstract][Full Text] [Related]
19. Studies on blood clotting factors in man after massive liver resection. Niléhn JE; Nilsson IM; Aronsen KF; Ericsson B Acta Chir Scand; 1967; 133(3):189-95. PubMed ID: 6030166 [No Abstract] [Full Text] [Related]
20. Evidence against vitamin K deficiency in normal neonates. Malia RG; Preston FE; Mitchell VE Thromb Haemost; 1980 Dec; 44(3):159-60. PubMed ID: 7466743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]